|
65679716212eaade2e0ee1d0
|
2020
|
Sweden
|
The Swedish Research Council
|
2018290970
|
2018-05024
|
3
|
Sri Lanka
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.042537
|
0
|
0
|
|
0.042537
|
0
|
0
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
AUTONOMOUS VISUAL DETECTION OF... BIO-HAZARDS LOCATIONS WITH AERIAL DRONES
more
|
Autonomous Visual Detection of... Bio-hazards Locations with Aerial Drones
more
|
Dengue and Zika are arboviral ...viruses that affect a significant portion of the world population causing many deaths. While there is no direct correlation between the income level and the possibility of being infected by the dengue virus, the economic impact on the poor is much larger since the funds spent by households below the poverty-line for the treatment of dengue amounts to 93.7% of their monthly per capita income even though free health care is available in Sri Lanka.The main vectors species of the Dengue and Zika viruses are mosquitoes that breed in very slow-flowing or standing water pools. It is important to reduce and control such breeding grounds to contain the spread of the diseases. We propose to use drones, unmanned micro aerial vehicles (UAV), to locate mosquito breeding grounds. UAVs equipped with cameras, accelerometers and other sensors can provide close-range aerial-inspection-capabilities. Using drones is a low-cost and hence sustainable solution. The main scientific challenges are to conceive visual-based, active sensing functionality to allow drones autonomously locate the relevant sites with little to no human intervention. Further, drones must be enabled to maneuver in confined areas to carry out the required tasks in built-up urban environments. Lastly, we must adaptively coordinate the operation of multiple drones to balance the application load among available resources, particularly with respect to the limited battery lifetime.
more
|
0
|
12250
|
Infectious disease control
|
3.3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Uppsala universitet
|
|
|
|
65679717212eaade2e0ee1d1
|
2020
|
Sweden
|
The Swedish Research Council
|
2018290941
|
2018-04468
|
3
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.130297
|
0
|
0
|
|
0.130297
|
0
|
0
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
IMMUNITY TO MALARIA: IMPORTANC...E OF PARASITE DIVERSITY AND HOST MEMORY
more
|
Immunity to malaria: importanc...e of parasite diversity and host memory
more
|
Malaria is a potentially fatal... infection in non-immune individuals. An efficacious vaccine is urgently needed. Given the extensive diversity of many of the potential vaccine targets, it is important to begin to understand how this diversity can be overcome to inform vaccine development. The aim of this project is to elucidate the mechanisms of acquisition and maintenance of immunity to malaria, focusing on antigen diversity and immunological memory. A novel innovative assay that allows for analyses of MBC responses against multiple antigens simultaneously and cross-reactivity on cellular level will be used. The studies are performed in well-defined and closely monitored cohorts in Kenya, as well as travellers in Sweden. Individuals returning from the tropics, and who are subsequently treated for malaria in a malaria-free area offer a unique opportunity to study infection and immunological memory in the absence of re-exposure. We will assess the breadth, magnitude and longevity of humoral and cellular immune responses in individuals with first and repeated infections. We will study how the preexisting immune repertoire predicts the outcome of an infection in semi-immune adult volunteers in Kenya. In a cohort of children we will assess these antimalrial immune responses and how coinfecting asymptomatic malaria infections impacts on the immune responses and outcome. The overall aim is to contribute to the development of an efficacious multicomponent vaccine against malaria.
more
|
0
|
12262
|
Malaria control
|
3.3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
|
65679717212eaade2e0ee1d2
|
2020
|
Sweden
|
The Swedish Research Council
|
2019290004
|
2019-03715_1
|
3
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.062499
|
0
|
0
|
|
0.062499
|
0
|
0
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
EXPLORATION OF EAST AFRICAN ME...DICINAL HERBS IN THE SEARCH FOR NOVEL ANTIBACTERIAL AGENTS
more
|
Exploration of East African Me...dicinal Herbs in the Search for Novel Antibacterial Agents
more
|
Antimicrobial resistance has b...ecome a major threat to human health and development. As our currently used antibiotics lose efficiency, we risk rapidly increasing number of untreatable infections leading to an increased number of lethal cases, longer hospital stays, and related suffering and economic burden. Antibiotic resistance is expected to hit developing countries especially hard, with 90% of the lethal infections predicted to happen in Africa and Asia.This study aims to make use of East African indigenous knowledge to use natural resources in finding new ways to control bacterial infections. Following an ethnomedical survey, medicinal plants will be collected in Kenya and Tanzania. Their constituents will be isolated, and identified by NMR and MS analyses. The bioactivity and toxicity of the isolated constituents will be determined using bacterial and cell-based assays. The biochemical pathways targeted by the most promising bioactive substances will be identified by chemical genomics. Advanced NMR techniques will subsequently be used to identify the binding mode of the substances to their protein targets to support their development into drugs.Besides achieving high scientific goals, the project aims the multidisciplinary training of East African PhD students. It will support the economic development of East Africa by strategic knowledge transfer and by promoting patient safety on the use of plants as a result of the scientific investigation of ethnomedical practices.
more
|
0
|
43082
|
Research/scientific institutio...ns
more
|
9.5
|
IV.2. Other Multisector
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Uppsala universitet
|
|
|
|
65679717212eaade2e0ee1d3
|
2020
|
Sweden
|
The Swedish Research Council
|
2019290029
|
2019-04150_1
|
3
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.094733
|
0
|
0
|
|
0.094733
|
0
|
0
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
IDENTIFICATION OF BACTERIAL IN...FECTIONS AND ANTIBIOTIC RESISTANCE IN LOW INCOME COUNTRIES BY RAPID OPTICAL DNA MAPPING
more
|
Identification of bacterial in...fections and antibiotic resistance in low income countries by rapid optical DNA mapping
more
|
Antibiotic resistance is one o...f the main threats to global health. The situation is particularly alarming in Low- and Middle-Income Countries (LMICs) since surveillance systems and easy-to-use tools for monitoring are lacking. The goal of this project is to use Optical DNA Mapping (ODM) as a genetic tool in LMICs. ODM is a method for coarse genetic analysis of bacteria that identifies the bacteria and reveals the resistance genes they are carrying. The method will be implemented at the neonatal ward at Muhimbili National Hospital (MNH) in Dar es Salaam, Tanzania. We have selected this setting for several reasons. First of all, Tanzania is one of many LMICs where simple microscopes are used in the clinical setting to diagnose tuberculosis. We will in this project repurpose these microscopes for ODM, which means that there is no extra cost for infrastructure. Second, we selected neonates because these patients are the most sensitive to resistant infections and have a high mortality. We therefore believe that any intervention that will result from this project will have immediate impact regarding decreased mortality. The project includes development of the ODM assay in Sweden, including adaptation to simple microscopy, a screen for resistant bacteria at the neonatal ward at MNH, teaching of staff at MNH in handling the ODM technique and finally implementation of ODM in routine testing in the neonatal ward at MNH.
more
|
0
|
12182
|
Medical research
|
3.b
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Chalmers tekniska högskola
|
|
|
|
65679717212eaade2e0ee1d4
|
2020
|
Sweden
|
The Swedish Research Council
|
2018290960
|
2018-04860
|
3
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.135726
|
0
|
0
|
|
0.135726
|
0
|
0
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
EVALUATING THE IMPACT OF CASH ...TRANSFERS PLUS ON TUBERCULOSIS OUTCOMES IN UGANDA: THE EXACT TB STUDY
more
|
Evaluating the Impact of Cash ...Transfers Plus on Tuberculosis Outcomes in Uganda: the ExaCT TB Study
more
|
Tuberculosis (TB) is the world...'s number one infectious killer and a public health threat, especially in low-middle-income countries. Poor case detection is a critical gap in TB care, where 40% of the world's 10 million cases are not detected (WHO 2017). Many of these patients are lost in the pre-treatment period, up to 83% in Uganda (Shete 2017). A major reason for this is the social and economic barriers that impede access to care (Shete 2015). Accordingly, WHO's End TB Strategy proposes the use of social protection interventions as part of TB care (Uplekar 2015). How best to implement and scale-up these interventions is still unknown.The purpose of our research is to develop an evidence base for the effectiveness of social protection interventions in enabling completion of diagnostic evaluation and treatment initiation for TB patients in Uganda. We will use formative mixed-methods research to identify social and economic barriers that impede access and adherence to care. We will design and evaluate a context specific, multi-faceted social protection intervention to overcome these barriers. Our outcomes will be the proportion of: (1) diagnosed patients who initiate TB treatment, (2) TB affected households who suffer catastrophic costs. Working closely with the Ugandan government, our results will be used to effect changes in health and development policy to improve health outcomes for TB patients, and to reduce the socio-economic risks for this vulnerable population.
more
|
0
|
12263
|
Tuberculosis control
|
3.3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
|
65679717212eaade2e0ee1d5
|
2020
|
Sweden
|
The Swedish Research Council
|
2019290006
|
2019-03715_3
|
3
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.062499
|
0
|
0
|
|
0.062499
|
0
|
0
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
EXPLORATION OF EAST AFRICAN ME...DICINAL HERBS IN THE SEARCH FOR NOVEL ANTIBACTERIAL AGENTS
more
|
Exploration of East African Me...dicinal Herbs in the Search for Novel Antibacterial Agents
more
|
Antimicrobial resistance has b...ecome a major threat to human health and development. As our currently used antibiotics lose efficiency, we risk rapidly increasing number of untreatable infections leading to an increased number of lethal cases, longer hospital stays, and related suffering and economic burden. Antibiotic resistance is expected to hit developing countries especially hard, with 90% of the lethal infections predicted to happen in Africa and Asia.This study aims to make use of East African indigenous knowledge to use natural resources in finding new ways to control bacterial infections. Following an ethnomedical survey, medicinal plants will be collected in Kenya and Tanzania. Their constituents will be isolated, and identified by NMR and MS analyses. The bioactivity and toxicity of the isolated constituents will be determined using bacterial and cell-based assays. The biochemical pathways targeted by the most promising bioactive substances will be identified by chemical genomics. Advanced NMR techniques will subsequently be used to identify the binding mode of the substances to their protein targets to support their development into drugs.Besides achieving high scientific goals, the project aims the multidisciplinary training of East African PhD students. It will support the economic development of East Africa by strategic knowledge transfer and by promoting patient safety on the use of plants as a result of the scientific investigation of ethnomedical practices.
more
|
0
|
43082
|
Research/scientific institutio...ns
more
|
9.5
|
IV.2. Other Multisector
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Uppsala universitet
|
|
|
|
65679718212eaade2e0ee1d6
|
2020
|
Sweden
|
The Swedish Research Council
|
2019290066
|
2019-05170
|
3
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0.11401
|
0
|
0
|
|
0.11401
|
0
|
0
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
DEVELOPMENT AND CLINICAL EVALU...ATION OF AN EQUITABLE DIAGNOSTIC SOLUTION FOR SEVERE FEVER IN CHILDREN: FROM PATIENT TO LAB-ON-A-CHIP AND BACK
more
|
Development and clinical evalu...ation of an equitable diagnostic solution for severe fever in children: from patient to lab-on-a-chip and back
more
|
Diagnostic devices for point-o...f-care are increasingly recognized as critical to meeting global health priorities, and are a cornerstone of infectious and non-infectious disease detection as well as clinical case management and control. Disadvantaged populations often lack access to well-equipped laboratory infrastructure, hindering efforts to control disease impact, spread, and resulting in a major source of health inequity. The Division of Nanobiotechnology at KTH Royal Institute of Technology has been active in developing and prototyping rapid point-of-care diagnostic tests suitable for resource-limited settings. In collaboration with the Mbarara University of Science and Technology, the Mbarara Regional University Hospital and Doctors Without Border's Epicentre, we will prototype and test a novel molecular diagnostic tool thatcan rapidly detect an infectious disease agent known to cause neurological infections such as meningitis.This postdoctoral research project aim at characterise and prototype an affordable, rapid, specific, and sensitive, POC tool for use in children with suspected nervous system infection and to evaluate its clinical usability in resource-limited setting. In conclusion, developing an affordable, easy to use POC that can aid medical scientists and clinicians in rural settings has potential to close the diagnostic gap between low and high resource setting. This project is an interdisciplinary cooperation between Uganda and Sweden.
more
|
0
|
12182
|
Medical research
|
3.b
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Kungliga Tekniska högskolan
|
|
|
|
65679718212eaade2e0ee1d7
|
2020
|
Sweden
|
The Swedish Research Council
|
2020290807A
|
2020-05494
|
1
|
Cameroon
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.086865
|
0
|
0
|
0
|
0.086865
|
0
|
0
|
0
|
0
|
0.086865
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
MALARIA, DIABETES AND METABOLI...C SYNDROME: INVESTIGATING THE DOUBLE BURDEN OF DISEASE
more
|
Malaria, diabetes and metaboli...c syndrome: investigating the double burden of disease
more
|
The aim of this collaborative ...project is to investigate whether diabetes and obesity affects the risk of severe malaria, and whether these underlying conditions impact on the susceptibility to chronic asymptomatic parasitemia and antibody mediated immunity to malaria in adults. Many sub-Saharan African countries are facing an increase in non-communicable diseases (NCDs), such as diabetes, obesity and metabolic syndrome due to lifestyle changes. At the same time infectious disease such as malaria remain highly endemic in these same areas. A recent study in Sweden detected a markedly increased risk of severe malaria in travellers with diabetes and obesity. Whether this is also found in endemic areas is yet to be confirmed. The purpose of this project is to establish a collaboration between institutions in Cameroon and Sweden, and to develop research projects to address the interplay between NCDs and malaria. We will perform a hospital-based study to assess disease severity and comorbidities. In addition, we will set up a cohort study to assess malaria parasite prevalence and immunity, as well as progress of diabetes. The proposed collaboration builds on highly complementary expertise that will enable generation of novel interdisciplinary findings of high public health importance. The collaboration includes workshops, seminars, research visits and planned PhD, and will be mutually beneficial for the research and development of both partners.
more
|
|
12262
|
Malaria control
|
3.3
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Karolinska Institutet
|
|
|
|
6567971f212eaade2e0ee1d8
|
2017
|
Switzerland
|
Swiss Agency for Development a...nd Co-operation
more
|
2014005443
|
7F-09203.01.51
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.170511
|
0
|
0
|
0
|
0.170511
|
0
|
0
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
DEMONSTRATION PROJECTS FOR INN...OVATIVE HEALTH RESEARCH AND DEVELOPMENT
more
|
Demonstration projects for inn...ovative health research and development
more
|
A major global health concern ...is the gap in research and development (R&D) of medical products against diseases disproportionately affecting poor people in developing countries. The World Health Organization (WHO) has selected several novel R&D projects. Through innovative approaches to coordination and financing of R&D, they aim to develop a series of cost-effective diagnostic kits and treatments for diseases such as leishmaniasis.
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
|
|
|
|
65679721212eaade2e0ee1d9
|
2015
|
United Kingdom
|
DFID
|
2013000543
|
203085-101
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
15.2788
|
0
|
0
|
0
|
15.2788
|
0
|
|
|
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
DFID-MEDICAL RESEARCH COUNCIL ...CONCORDAT 2013-18
more
|
DFID-Medical Research Council ...Concordat 2013-18
more
|
To produce high quality outcom...es in biomedical and health research, designed to tackle the priority health problems of developing countries. In the long-term the research will contribute to improved health of the poorest people.
more
|
The expected outputs from this... funding will include:
1. High quality biomedical and health research (including clinical trials) with a focus on translational and implementation research, relevant to developing countries, which can include public health research; health services research and health systems research
2. High quality treatment and prevention research (including clinical trials) into HIV and AIDS, TB, malaria and other neglected tropical diseases is conducted in low income countries with match funding through European and Developing Countries Clinical Trials Partnership (EDCTP)
3. Capacity development activities to strengthen the scientific research base for both individuals and institutions, particularly in Sub Saharan Africa (Developing countries, unspecified 203085-101 DFID-Medical Research Council Concordat 2013-18 p.2)
more
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think-tank
more
|
|
|
|
65679721212eaade2e0ee1da
|
2016
|
United Kingdom
|
Department for International D...evelopment
more
|
2013001189
|
204076-101
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0
|
1.54926
|
0
|
0
|
0
|
1.54926
|
0
|
0
|
|
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
TO FUND THE NEW INSECTICIDES T...O CONTROL INSECTS THAT CARRY MALARIA AND SOME OF THE NEGLECTED TROPICAL DISEASES.
more
|
To fund the new insecticides t...o control insects that carry malaria and some of the neglected tropical diseases.
more
|
To research and develop new in...secticides for malaria control through public private partnership. This research will advance the development of new insecticides and help mitigate the threat posed by insecticide resistance on existing tools – long lasting i
more
|
The main 5 year outputs associ...ated with DFID funding and contributing towards the achievement of this outcome will be:
• at least one new class of public health pesticides
• epidemiological field evaluation of one new long lasting insecticide treated net to assess its potential against pyrethroid resistant insects.
• an insecticide quantification kit to help with monitoring resistance taken up by one or more regional commercial manufacturer for Africa.
• the application of a decision support system by at least one African Malaria Control programme
(Developing countries, unspecified 204076-101 To fund the new insecticides to control insects p.3)
more
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
31000
|
Public-Private Partnerships (P...PP)
more
|
Public-Private Partnership (PP...P)
more
|
|
|
|
65679721212eaade2e0ee1db
|
2015
|
United Kingdom
|
DFID
|
2013001212
|
204139-101
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
1.83346
|
0
|
0
|
0
|
1.83346
|
0
|
0
|
|
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
PATH PRODUCT DEVELOPMENT PARTN...ERSHIP PROGRAMME 2013 - 2018
more
|
PATH Product Development Partn...ership Programme 2013 - 2018
more
|
'To reduce poverty through inv...estment in research to develop effective and affordable, diagnostics, treatment, drugs and vaccines for diarrhoea and malaria. In the longer term this has the potential to significantly reduce death and illness among the poor
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
21000
|
International NGOs
|
INTERNATIONAL NGO
|
|
|
|
65679722212eaade2e0ee1dc
|
2015
|
United Kingdom
|
DFID
|
2013001214
|
204139-103
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
3
|
10
|
110
|
B01
|
0
|
1.52788
|
0
|
0
|
0
|
1.52788
|
0
|
0
|
|
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
PATH PRODUCT DEVELOPMENT PARTN...ERSHIP PROGRAMME 2013 - 2018
more
|
PATH Product Development Partn...ership Programme 2013 - 2018
more
|
'To reduce poverty through inv...estment in research to develop effective and affordable, diagnostics, treatment, drugs and vaccines for diarrhoea and malaria. In the longer term this has the potential to significantly reduce death and illness among the poor
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
21000
|
International NGOs
|
INTERNATIONAL NGO
|
|
|
|
65679722212eaade2e0ee1dd
|
2014
|
United Kingdom
|
BIS
|
2011800844
|
G0600129/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.115245
|
0.115245
|
0
|
0
|
0.115245
|
0.115245
|
0
|
0.115245
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
MITOCHONDRIAL FUNCTION IN BLOO...DSTREAM STAGE TRYPANOSOMES
more
|
Mitochondrial function in bloo...dstream stage trypanosomes
more
|
Mitochondrial function in bloo...dstream stage trypanosomes
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679722212eaade2e0ee1de
|
2014
|
United Kingdom
|
BIS
|
2011800884
|
G0801208/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.15209
|
0.15209
|
0
|
0
|
0.15209
|
0.15209
|
0
|
0.15209
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
MOLECULAR BASES OF TICK-BORNE ...FLAVIVIRUS TRANSMISSION
more
|
Molecular bases of tick-borne ...flavivirus transmission
more
|
Molecular bases of tick-borne ...flavivirus transmission
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679722212eaade2e0ee1df
|
2014
|
United Kingdom
|
BIS
|
2011800906
|
G0900278/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.333841
|
0.333841
|
0
|
0
|
0.333841
|
0.333841
|
0
|
0.333841
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
N-MYRISTOYL TRANSFERASE AS A D...RUG TARGET FOR ANTI-MALARIAL THERAPY
more
|
N-Myristoyl Transferase as a d...rug target for anti-malarial therapy
more
|
N-Myristoyl Transferase as a d...rug target for anti-malarial therapy
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679722212eaade2e0ee1e0
|
2014
|
United Kingdom
|
BIS
|
2011800929
|
G1000230-E01/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.611966
|
0.611966
|
0
|
0
|
0.611966
|
0.611966
|
0
|
0.611966
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
IMMUNOLOGY AND IMMUNOPATHOLOGY... OF VISCERAL LEISHMANIASIS
more
|
Immunology and Immunopathology... of visceral leishmaniasis
more
|
Immunology and Immunopathology... of visceral leishmaniasis
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679722212eaade2e0ee1e1
|
2014
|
United Kingdom
|
BIS
|
2011800939
|
G1001753/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.128535
|
0.128535
|
0
|
0
|
0.128535
|
0.128535
|
0
|
0.128535
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
TGF-BETA ACTIVATION BY GUT DEN...DRITIC CELLS: IDENTIFYING A CRITICAL PATHWAY IN REGULATION OF CHRONIC PARASITIC INFECTION
more
|
TGF-beta activation by gut den...dritic cells: identifying a critical pathway in regulation of chronic parasitic infection
more
|
TGF-beta activation by gut den...dritic cells: identifying a critical pathway in regulation of chronic parasitic infection
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679723212eaade2e0ee1e2
|
2014
|
United Kingdom
|
BIS
|
2011800945
|
G1002297/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.0386358
|
0.0386358
|
0
|
0
|
0.0386358
|
0.0386358
|
0
|
0.0386358
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
NEW METHODS FOR TRACKING EMERG...ENT INFECTIONS: INTEGRATING PATHOGEN GENOMIC AND GEOGRAPHIC INFORMATION SYSTEM DATA
more
|
New methods for tracking emerg...ent infections: integrating pathogen genomic and geographic information system data
more
|
New methods for tracking emerg...ent infections: integrating pathogen genomic and geographic information system data
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679723212eaade2e0ee1e3
|
2014
|
United Kingdom
|
BIS
|
2011800949
|
G1002586/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.0513034
|
0.0513034
|
0
|
0
|
0.0513034
|
0.0513034
|
0
|
0.0513034
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
LEAD SERIES DEVELOPMENT & OPTI...MISATION OF A NEW DRUG AGAINST ACTIVE AND LATENT TUBERCULOSIS
more
|
LEAD SERIES DEVELOPMENT & OPTI...MISATION OF A NEW DRUG AGAINST ACTIVE AND LATENT TUBERCULOSIS
more
|
LEAD SERIES DEVELOPMENT & OPTI...MISATION OF A NEW DRUG AGAINST ACTIVE AND LATENT TUBERCULOSIS
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679723212eaade2e0ee1e4
|
2014
|
United Kingdom
|
BIS
|
2011800952
|
G1100085/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.476172
|
0.476172
|
0
|
0
|
0.476172
|
0.476172
|
0
|
0.476172
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
SIMULTANEOUS PARENTERAL AND PU...LMONARY IMMUNISATION AGAINST TUBERCULOSIS
more
|
Simultaneous parenteral and pu...lmonary immunisation against tuberculosis
more
|
Simultaneous parenteral and pu...lmonary immunisation against tuberculosis
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679723212eaade2e0ee1e5
|
2014
|
United Kingdom
|
BIS
|
2011800953
|
G1100086/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.128121
|
0.128121
|
0
|
0
|
0.128121
|
0.128121
|
0
|
0.128121
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
DEVELOPMENTAL CLINICAL STUDIES... - CLINICAL EVALUATION OF AN ADCH63-MVA PVDBP_RII VACCINE FOR BLOOD-STAGE PLASMODIUM VIVAX
more
|
Developmental Clinical Studies... - Clinical evaluation of an AdCh63-MVA PvDBP_RII vaccine for blood-stage Plasmodium vivax
more
|
Developmental Clinical Studies... - Clinical evaluation of an AdCh63-MVA PvDBP_RII vaccine for blood-stage Plasmodium vivax
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679723212eaade2e0ee1e6
|
2014
|
United Kingdom
|
BIS
|
2011800970
|
MC_U117532063
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.99998
|
1.99998
|
0
|
0
|
1.99998
|
1.99998
|
0
|
1.99998
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
PROTEASES IN HOST CELL INVASIO...N BY THE MALARIA PARASITE
more
|
Proteases in host cell invasio...n by the malaria parasite
more
|
Proteases in host cell invasio...n by the malaria parasite
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679723212eaade2e0ee1e7
|
2014
|
United Kingdom
|
BIS
|
2011800971
|
MC_U117532067
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
2.0504
|
2.0504
|
0
|
0
|
2.0504
|
2.0504
|
0
|
2.0504
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
MALARIA PARASITE PROTEINS AND ...ERYTHROCYTE INVASION
more
|
malaria parasite proteins and ...erythrocyte invasion
more
|
malaria parasite proteins and ...erythrocyte invasion
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679724212eaade2e0ee1e8
|
2014
|
United Kingdom
|
BIS
|
2011800974
|
MC_U117581288
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
2.03359
|
2.03359
|
0
|
0
|
2.03359
|
2.03359
|
0
|
2.03359
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
MYCOBACTERIA AND THE HOST RESP...ONSE
more
|
Mycobacteria and the host resp...onse
more
|
Mycobacteria and the host resp...onse
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679724212eaade2e0ee1e9
|
2014
|
United Kingdom
|
BIS
|
2011800975
|
MC_U117584248
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
2.15123
|
2.15123
|
0
|
0
|
2.15123
|
2.15123
|
0
|
2.15123
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
THE IMMUNE RESPONSE TO MALARIA...: REGULATION AND PROTECTIVE IMMUNITY
more
|
The immune response to malaria...: regulation and protective immunity
more
|
The immune response to malaria...: regulation and protective immunity
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679724212eaade2e0ee1ea
|
2014
|
UNICEF
|
UNICEF
|
2014002509
|
3300/A0/05/103/002
|
8
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.984602
|
0.984602
|
0
|
0
|
0.984602
|
0.984602
|
0
|
0
|
1
|
2
|
Classified as not health-speci...fic activity
more
|
|
100
|
3.2 INSTITUTIONAL CAPACITY BUI...LDING
more
|
3.2 INSTITUTIONAL CAPACITY BUI...LDING
more
|
3.2 INSTITUTIONAL CAPACITY BUI...LDING
more
|
|
11120
|
Education facilities and train...ing
more
|
|
I.1.a. Education, Level Unspec...ified
more
|
|
|
|
|
|
|
65679726212eaade2e0ee1eb
|
2014
|
United Kingdom
|
BIS
|
2011800934
|
G1000808/1
|
3
|
Gambia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.622591
|
0.622591
|
0
|
0
|
0.622591
|
0.622591
|
0
|
0.622591
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
NATURAL KILLER CELLS AS EFFECT...ORS OF VACCINE-INDUCED IMMUNITY
more
|
Natural Killer cells as effect...ors of vaccine-induced immunity
more
|
Natural Killer cells as effect...ors of vaccine-induced immunity
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679726212eaade2e0ee1ec
|
2014
|
United Kingdom
|
BIS
|
2011800994
|
MC_U190071468
|
8
|
Gambia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.22798
|
1.22798
|
0
|
0
|
1.22798
|
1.22798
|
0
|
1.22798
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
VACCINOLOGY TB CASE CONTACT ST...UDY
more
|
VACCINOLOGY TB case contact st...udy
more
|
VACCINOLOGY TB case contact st...udy
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679726212eaade2e0ee1ed
|
2014
|
United Kingdom
|
BIS
|
2011801017
|
MC_UP_A900_1122
|
8
|
Gambia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.95013
|
0.95013
|
0
|
0
|
0.95013
|
0.95013
|
0
|
0.95013
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
VACCINOLOGY RESEARCH MRC UNIT,... THE GAMBIA, THE
more
|
VACCINOLOGY Research MRC Unit,... The Gambia, The
more
|
VACCINOLOGY Research MRC Unit,... The Gambia, The
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679726212eaade2e0ee1ee
|
2014
|
United Kingdom
|
BIS
|
2011800938
|
G1001337/1
|
3
|
Ghana
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.568485
|
0.568485
|
0
|
0
|
0.568485
|
0.568485
|
0
|
0.568485
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
J GYAPONG, UNIVERSITY OF GHANA..., FILARIASIS ELIMINATION IN AFRICA: REFINING THE STRATEGIES THROUGH RESEARCH
more
|
J GYAPONG, UNIVERSITY OF GHANA..., FILARIASIS ELIMINATION IN AFRICA: REFINING THE STRATEGIES THROUGH RESEARCH
more
|
J GYAPONG, UNIVERSITY OF GHANA..., FILARIASIS ELIMINATION IN AFRICA: REFINING THE STRATEGIES THROUGH RESEARCH
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679726212eaade2e0ee1ef
|
2014
|
United Kingdom
|
BIS
|
2011800931
|
G1000527/1
|
3
|
Kenya
|
South of Sahara
|
Other LICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.378716
|
0.378716
|
0
|
0
|
0.378716
|
0.378716
|
0
|
0.378716
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
CLINICAL AND IMMUNOLOGICAL EVA...LUATION OF T CELL- AND ANTIBODY-INDUCING VIRAL VECTOR VACCINES AGAINST BLOOD-STAGE MALARIA
more
|
Clinical and Immunological Eva...luation of T cell- and Antibody-Inducing Viral Vector Vaccines against Blood-Stage malaria
more
|
Clinical and Immunological Eva...luation of T cell- and Antibody-Inducing Viral Vector Vaccines against Blood-Stage malaria
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679727212eaade2e0ee1f0
|
2014
|
UNICEF
|
UNICEF
|
2014002558
|
0990/A0/06/001/006
|
8
|
Democratic Republic of the Con...go
more
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.443672
|
0.443672
|
0
|
0
|
0.443672
|
0.443672
|
0
|
10
|
1
|
11
|
Classified as not health-speci...fic activity
more
|
|
100
|
IR 1.6 ACCES A L#ENVIRONNEMENT... ASSAINI
more
|
IR 1.6 ACCES A L#ENVIRONNEMENT... ASSAINI
more
|
IR 1.6 ACCES A L#ENVIRONNEMENT... ASSAINI
more
|
|
14031
|
Basic drinking water supply
|
|
I.4. Water Supply & Sanitation
|
|
|
|
|
|
|
65679727212eaade2e0ee1f1
|
2014
|
UNFPA
|
UNFPA
|
2014002488
|
|
1
|
Malawi
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00453648
|
0.00453648
|
0
|
0
|
0.00453648
|
0.00453648
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
ANALYSIS ON POPULATION DYNAMIC...S
more
|
Output 13: Analysis on populat...ion dynamics
more
|
Malawi - Lilongwe - Outcome 4:... Strengthened national policies and international development agendas through integration of evidence-based analysis on population dynamics
more
|
Analysis on population dynami...cs
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
|
|
|
|
65679727212eaade2e0ee1f2
|
2014
|
United Kingdom
|
BIS
|
2011800977
|
MC_U117588499
|
8
|
South Africa
|
South of Sahara
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.512599
|
0.512599
|
0
|
0
|
0.512599
|
0.512599
|
0
|
0.512599
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
STEROID REGULATED IMMUNE RESPO...NSES IN TUBERCULOSIS
more
|
Steroid regulated immune respo...nses in tuberculosis
more
|
Steroid regulated immune respo...nses in tuberculosis
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679728212eaade2e0ee1f3
|
2014
|
United Kingdom
|
BIS
|
2011801021
|
MC_UP_A910_1025
|
8
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.534036
|
0.534036
|
0
|
0
|
0.534036
|
0.534036
|
0
|
0.534036
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
BASIC SCIENCE PROGRAMME /DISSE...CTING THE IMMUNOLOGICAL INTERPLAY BETWEEN POVERTY-RELAETED DISEASES AND HELMINTH INFECTION (IDEA PROJECT)
more
|
Basic Science Programme /Disse...cting the immunological interplay between poverty-relaeted diseases and helminth infection (IDEA Project)
more
|
Basic Science Programme /Disse...cting the immunological interplay between poverty-relaeted diseases and helminth infection (IDEA Project)
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Developing country-based NGO
|
|
|
|
65679728212eaade2e0ee1f4
|
2015
|
UNICEF
|
UNICEF
|
2015003763
|
4140/A0/04/115/010
|
8
|
Syrian Arab Republic
|
Middle East
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0741477
|
0.0741477
|
0
|
0
|
0.0741477
|
0.0741477
|
0
|
10
|
1
|
11
|
Classified as not health-speci...fic activity
more
|
|
100
|
IR 2.7 ACCESS
|
IR 2.7 ACCESS
|
IR 2.7 ACCESS
|
|
11230
|
Basic life skills for youth an...d adults
more
|
|
I.1.b. Basic Education
|
|
|
|
|
|
|
65679729212eaade2e0ee1f5
|
2015
|
United States
|
STATE
|
2015004547
|
65_10042
|
1
|
Chad
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0
|
0
|
0.036708
|
0
|
0
|
0
|
0.036708
|
0
|
0
|
0
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
100
|
ASSISTANCE FOR SUDANESE REFUGE...ES AND CONFLICT-AFFECTED POPULATIONS IN WADI FIRA REGION
more
|
Assistance for Sudanese Refuge...es and Conflict-Affected Populations in Wadi Fira Region
more
|
United States Population Migra...tion and Refugee Assistance, Appropriation 1143. Protection and assistance needs of refugees, migrants and conflict vicitms worldwide. [International Medical Corps]
more
|
|
72010
|
Material relief assistance and... services
more
|
|
VIII.1. Emergency Response
|
21000
|
International NGOs
|
International Medical Corps
|
|
|
|
6567972a212eaade2e0ee1f6
|
2015
|
United Kingdom
|
BIS
|
2015004810
|
BIS-NF14AMS-0042
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
G01
|
0.213947
|
0.213947
|
0
|
0
|
0.213947
|
0.213947
|
0
|
|
|
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
ACADEMY OF MEDICAL SCIENCES NE...WTON FUND PROGRAMME DELIVERY COSTS
more
|
Academy of Medical Sciences Ne...wton Fund Programme Delivery costs
more
|
Newton Fund. Programme Deliver...y costs for Academy of Medical Sciences
more
|
The Newton Fund is part of the... UK’s official development assistance. Its aim is to develop science and innovation partnerships that promote the economic development and social welfare of partner countries.
The Newton Fund was launched in 2014 and originally consisted of £75 million each year for 5 years. In the 2015 UK Spending Review it was agreed to extend and expand the fund. The Newton Fund was extended from 2019 to 2021 and will expand to £150 million per year by 2021, resulting in a £735 million UK investment to 2021, with partner countries providing matched resources within the fund.
more
|
91010
|
Administrative costs (non-sect...or allocable)
more
|
|
Administrative Costs of Donors
|
11000
|
Donor government
|
Donor Government
|
|
|
|
6567972b212eaade2e0ee1f7
|
2015
|
UNICEF
|
UNICEF
|
2015005571
|
0060/A0/07/882/005
|
8
|
Afghanistan
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.502034
|
0.502034
|
0
|
0
|
0.502034
|
0.502034
|
0
|
10
|
1
|
11
|
Classified as not health-speci...fic activity
more
|
|
100
|
WASH IN SCHOOLS
|
WASH IN SCHOOLS
|
WASH IN SCHOOLS
|
|
14030
|
Basic drinking water supply an...d basic sanitation
more
|
|
I.4. Water Supply & Sanitation
|
|
|
|
|
|
|
6567972b212eaade2e0ee1f8
|
2015
|
UNFPA
|
UNFPA
|
2015003941
|
|
3
|
Mauritania
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0.0119166
|
0
|
0
|
|
0.0119166
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
DATA ON POPULATION AND DEVELOP...MENT
more
|
Output 12: Data on Population ...and Development
more
|
Mauritania - Nouakchott. Outpu...t 12: Strengthened national capacity for production and dissemination of quality disaggregated data on population and development issues that allows for mapping of demographic disparities and socio-economic inequalities, and for programming in humanitarian settings
more
|
Data on Population and Develop...ment
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
12000
|
Recipient government
|
Governments
|
|
|
|
6567972c212eaade2e0ee1f9
|
2015
|
UNICEF
|
UNICEF
|
2015005347
|
2910/A0/04/301/005
|
8
|
Morocco
|
North of Sahara
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.212087
|
0.212087
|
0
|
0
|
0.212087
|
0.212087
|
0
|
0
|
0
|
1
|
Classified as not health-speci...fic activity
more
|
|
100
|
INTEGRATED PROTECTION POLICY
|
INTEGRATED PROTECTION POLICY
|
INTEGRATED PROTECTION POLICY
|
|
16010
|
Social/welfare services
|
|
I.6. Other Social Infrastructu...re & Services
more
|
|
|
|
|
|
|
6567972c212eaade2e0ee1fa
|
2015
|
United Kingdom
|
BIS
|
2015004829
|
BIS-MRC-15-0139
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.680856
|
0.217711
|
0
|
0
|
0.680856
|
0.217711
|
0
|
0.680856
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
IDENTIFYING AND CHARACTERISING... DEVELOPMENTAL REGULATORS OF HUMAN INFECTIOUS LEISHMANIA
more
|
Identifying and Characterising... Developmental Regulators of Human Infectious Leishmania
more
|
Medical Research Council. Rese...arch grant to investigate host parasite interaction of leishmania
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think-tank
more
|
|
|
|
6567972e212eaade2e0ee1fb
|
2015
|
UNICEF
|
UNICEF
|
2015004655
|
4920/A0/05/030/004
|
1
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0
|
0.256486
|
0
|
0
|
0
|
0.256486
|
0
|
1
|
1
|
Classified as not health-speci...fic activity
more
|
|
100
|
EDUCATION EMERGENCY
|
EDUCATION EMERGENCY
|
EDUCATION EMERGENCY
|
|
72050
|
Relief co-ordination; protecti...on and support services
more
|
|
VIII.1. Emergency Response
|
|
|
|
|
|
|
6567972e212eaade2e0ee1fc
|
2015
|
UNICEF
|
UNICEF
|
2015004468
|
2760/A0/03/022/002
|
8
|
Mali
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.336492
|
0.336492
|
0
|
0
|
0.336492
|
0.336492
|
0
|
10
|
1
|
11
|
Classified as not health-speci...fic activity
more
|
|
100
|
OUTPUT 9.2 PGMS DE TRANSFERTS ...SOCIAUX
more
|
OUTPUT 9.2 PGMS DE TRANSFERTS ...SOCIAUX
more
|
OUTPUT 9.2 PGMS DE TRANSFERTS ...SOCIAUX
more
|
|
16010
|
Social/welfare services
|
|
I.6. Other Social Infrastructu...re & Services
more
|
|
|
|
|
|
|
6567972e212eaade2e0ee1fd
|
2015
|
UNFPA
|
UNFPA
|
2015004064
|
|
3
|
Mexico
|
North & Central America
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0.00041021
|
0
|
0
|
|
0.00041021
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
ANALYSIS ON POPULATION DYNAMIC...S
more
|
Output 13: Analysis on populat...ion dynamics
more
|
Mexico - Mexico City. Output 1...3: Increased availability of evidence through cutting-edge in-depth analysis on population dynamics, sexual and reproductive health, HIV and their linkages to poverty eradication and sustainable development
more
|
Analysis on population dynami...cs
more
|
43030
|
Urban development and manageme...nt
more
|
|
IV.2. Other Multisector
|
|
|
UNFPA
|
|
|
|
6567972e212eaade2e0ee1fe
|
2015
|
UNICEF
|
UNICEF
|
2015004516
|
2970/A0/05/601/007
|
8
|
Nepal
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0233828
|
0.0233828
|
0
|
0
|
0.0233828
|
0.0233828
|
0
|
10
|
1
|
12
|
Classified as not health-speci...fic activity
more
|
|
100
|
1.7 ECONOMIC ANALYSIS,SOCIAL P...ROT , DATA
more
|
1.7 ECONOMIC ANALYSIS,SOCIAL P...ROT , DATA
more
|
1.7 ECONOMIC ANALYSIS,SOCIAL P...ROT , DATA
more
|
|
15110
|
Public sector policy and admin...istrative management
more
|
|
I.5.a. Government & Civil Soci...ety-general
more
|
|
|
|
|
|
|
6567972f212eaade2e0ee1ff
|
2015
|
UNFPA
|
UNFPA
|
2015005106
|
|
3
|
Papua New Guinea
|
Oceania
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0.002223
|
0
|
0
|
|
0.002223
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
DATA ON POPULATION AND DEVELOP...MENT
more
|
Output 12: Data on Population ...and Development
more
|
Papua New Guinea- Port Moresby.... Output 12: Strengthened national capacity for production and dissemination of quality disaggregated data on population and development issues that allows for mapping of demographic disparities and socio-economic inequalities, and for programming in humanitarian settings
more
|
Data on Population and Develop...ment
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
12000
|
Recipient government
|
Governments
|
|
|
|
6567972f212eaade2e0ee200
|
2015
|
UNICEF
|
UNICEF
|
2015005348
|
2690/A0/05/931/318
|
8
|
Malawi
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.308057
|
0.308057
|
0
|
0
|
0.308057
|
0.308057
|
0
|
0
|
1
|
2
|
Classified as not health-speci...fic activity
more
|
|
100
|
ESTABLISHMENT OF CP MODEL
|
ESTABLISHMENT OF CP MODEL
|
ESTABLISHMENT OF CP MODEL
|
|
16010
|
Social/welfare services
|
|
I.6. Other Social Infrastructu...re & Services
more
|
|
|
|
|
|
|
6567972f212eaade2e0ee201
|
2015
|
UNICEF
|
UNICEF
|
2015005390
|
0810/A0/04/886/003
|
8
|
Chad
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0630487
|
0.0630487
|
0
|
0
|
0.0630487
|
0.0630487
|
0
|
10
|
1
|
11
|
Classified as not health-speci...fic activity
more
|
|
100
|
OFFRE DE SCE MEDIA
|
OFFRE DE SCE MEDIA
|
OFFRE DE SCE MEDIA
|
|
15160
|
Human rights
|
|
I.5.a. Government & Civil Soci...ety-general
more
|
|
|
|
|
|
